Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-4.38x - 0.08x4.95x-5.38x-5.03x-.--% 17Cr
49.68x5.41x-2.43x8.45x37.67x38.95x-.--% 3.47TCr
-24.17x1.3x-0.53x6.05x-9.88x-9.17x-.--% 2.81TCr
17.15x3.01x0.67x4.22x11.65x13.67x1.71% 2.8TCr
-60.29x - -2.07x - -60.61x-59.57x-.--% 1.92TCr
-18.1x53.71x4.39x40.36x-19.85x-19.61x-.--% 1.84TCr
13.51x2.11x-0.91x2.67x7.53x8.14x-.--% 1.34TCr
24.35x2.02x1.03x4.27x12.38x15.83x-.--% 1.33TCr
2131.93x12.87x-19.79x25.28x286.48x1255.09x-.--% 1.24TCr
19.61x4.42x0.63x4.72x13.59x14.14x-.--% 1.23TCr
-112.34x24.45x-0.85x34.84x-189.28x-111.14x-.--% 977.65Cr
412.8x - -3.69x22.37x - 266.25x - 955.64Cr
-42.85x7.37x12.4x6.64x-55.2x-46.4x-.--% 731.81Cr
-24.64x13.34x0.59x9.54x-16.88x-19.39x-.--% 698.6Cr
30.56x5.55x0.31x10.19x31.91x34.53x0.43% 609.93Cr
23.73x6.1x0.96x - - - - 590.63Cr
-16.58x6.65x-0.64x - -17.68x-15.3x-.--% 589.33Cr
57.71x1.94x-2.43x3.51x15.95x29.15x0.31% 579.54Cr
-36.06x21.06x0.89x15.48x-64.79x-41.01x-.--% 485.62Cr
Average 128.51x 10.71x -0.60x 12.72x -1.32x 74.95x 0.14% 1.27TCr
Weighted average by Cap. 123.60x 10.19x -0.95x 12.38x 5.75x 72.30x 0.23%
Bio Therapeutic Drugs